Abstract
Cell and tissue therapies are about to revolutionize the treatment of a number of diseases, including: organ, replacement, cartilage, skin, autoimmune diseases, diabetes, neurodegenerative diseases, cancer and cardiovascular tissue damage. Although cell therapy is not a new phenomenon, what is new is the scope and versatility of research using stem cell and tissue therapeutics, and products based on combinations of cell therapy, gene manipulation, and tissue engineering.
The report provides world market projections 2002-2007, discusses market trends and issues including how bioethics debates are affecting development and what the best marketing models for these new therapies will be. The report also makes considered predictions about the companies and technologies to watch as the cell therapy industry evolves.